Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
8
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
12
users have liked this narrative
2
users have commented on this narrative
19
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
15
users have liked this narrative
4
users have commented on this narrative
16
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Apple
AN
AnalystLowTarget
Consensus Narrative from 36 Analysts
Rising Trade Tensions And Regulatory Woes Will Impair Margins
Key Takeaways Geopolitical pressures, regulatory challenges, and evolving supply chains threaten Apple's margins and introduce substantial operational uncertainty. Heavy dependence on iPhone and Services faces risk from market saturation, regulatory changes, and intensifying competition in both hardware and software.
View narrative
US$175.43
FV
31.4% overvalued
intrinsic discount
3.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
28 days ago
author updated this narrative
Hexcel
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Supply Chain Delays Will Challenge Airbus Production But Open Opportunities
Key Takeaways Hexcel's revenue and profitability are under pressure due to supply chain delays and reduced operating leverage in aerospace production. Tariff uncertainties and delayed aircraft production rates may impact Hexcel's cost structure and financial recovery.
View narrative
US$52.00
FV
17.6% overvalued
intrinsic discount
6.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
28 days ago
author updated this narrative
Air Lease
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Air Travel Deceleration And Fleet Obsolescence Will Erode Value
Key Takeaways Growing regulation, supply chain issues, and increased competition threaten long-term fleet expansion, profit margins, and revenue growth. Advances in decarbonization could obsolete parts of the fleet, raising depreciation risks and potentially reducing future earnings.
View narrative
US$50.99
FV
13.9% overvalued
intrinsic discount
6.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
28 days ago
author updated this narrative
ACI Worldwide
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Legacy Limitations Will Constrain Growth Yet Digital Solutions Offer Hope
Key Takeaways Slow migration from legacy systems and competition from agile fintechs threaten revenue stability and customer retention despite recent cloud and global expansion efforts. Heavy reliance on legacy deployments and concentration in banking and bill payment sectors expose margins and growth to sector downturns, contract risks, and volatile compliance costs.
View narrative
US$48.73
FV
3.5% undervalued
intrinsic discount
5.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
28 days ago
author updated this narrative
Krystal Biotech
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Uncertain Gene Therapy Dynamics Will Fuel Challenges Yet Spark Hope
Key Takeaways Reliance on Vyjuvek faces challenges from unpredictable patient treatment patterns, pricing pressures, and reimbursement risks, impacting both revenue visibility and long-term margin stability. Expanding into new indications through the pipeline and broader patient access drives costs and risk, particularly given high R&D investment and dependence on successful clinical outcomes.
View narrative
US$176.00
FV
18.2% undervalued
intrinsic discount
17.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
28 days ago
author updated this narrative
Moelis
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Automation And Regulation Will Constrict Traditional Advisory Business
Key Takeaways Disruptive shifts toward alternative capital-raising methods and automation are reducing Moelis' traditional market, exerting sustained pressure on revenue growth and profitability. Heavy reliance on senior bankers and cyclical deal activity makes Moelis vulnerable to volatile earnings, regulatory barriers, and challenges in talent retention.
View narrative
US$62.00
FV
15.1% overvalued
intrinsic discount
14.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
28 days ago
author updated this narrative
Supreme Industries
AN
AnalystHighTarget
Consensus Narrative from 24 Analysts
India's Urbanization And Advanced Polymers Will Fuel Enduring Demand
Key Takeaways Supreme's technology leadership and expanded portfolio position it for rapid earnings growth, superior margins, and aggressive share gains in a strengthening market. Comprehensive distribution, value-added products, and regulatory advantages drive resilient revenue growth, strong profitability, and sustained dominance over less sophisticated competitors.
View narrative
₹5.17k
FV
12.2% undervalued
intrinsic discount
16.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
28 days ago
author updated this narrative
Uno Minda
AN
AnalystHighTarget
Consensus Narrative from 19 Analysts
EV Adoption And IoT Will Expand Global Automotive Reach
Key Takeaways Uno Minda's aggressive expansion and advanced technology focus are driving significant revenue growth and margin improvement well beyond industry expectations. Global diversification and strong investment in automotive electronics and R&D uniquely position Uno Minda to benefit from rising demand for connected and autonomous vehicles.
View narrative
₹1.35k
FV
8.6% undervalued
intrinsic discount
26.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
28 days ago
author updated this narrative
Doximity
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Privacy Rules Will Squeeze Margins While Tools Will Support Recovery
Key Takeaways Rising compliance costs, platform fatigue, and stronger competition may compress margins and threaten Doximity's core revenue growth. Shifts in client digital marketing budgets and the move to integrated health IT platforms could increase customer churn and limit user expansion.
View narrative
US$50.00
FV
27.2% overvalued
intrinsic discount
9.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
28 days ago
author updated this narrative
Value any company in seconds
Popular companies